Dexamethasone and Lower Extremity Block Duration
- Registration Number
- NCT01756586
- Lead Sponsor
- University of Chicago
- Brief Summary
Dexamethasone has shown to prolong upper extremity blocks. No one ha studied its effect on lower extremity blocks. The study would evaluate that point.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- Age 18-75
- foot surgery
- no contraindication to regional anesthesia
Exclusion Criteria
- opioid dependent
- chronic pain condition
- peripheral neuropathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental Dexamethasone Bupivacaine with Dexamethasone Control Bupivacaine Plain bupivacaine Experimental Bupivacaine Bupivacaine with Dexamethasone
- Primary Outcome Measures
Name Time Method Increase in the Duration of Block 3 days
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain dexamethasone's prolongation of peripheral nerve blocks in lower extremities?
How does dexamethasone compare to other corticosteroids in extending bupivacaine analgesia duration for lower limb surgery?
Are there specific biomarkers that predict enhanced analgesic duration when combining dexamethasone with local anesthetics?
What adverse events are associated with dexamethasone adjunct use in peripheral nerve blocks and how are they managed?
How do combination therapies involving dexamethasone and liposomal bupivacaine impact postoperative pain management in orthopedic procedures?
Trial Locations
- Locations (1)
University of Chicago Medical Center
🇺🇸Chicago, Illinois, United States
University of Chicago Medical Center🇺🇸Chicago, Illinois, United States